Giorgio Minotti
Giorgio Minotti
Professore Ordinario di Farmacologia, UniversitÓ Campus Bio-Medico di Roma
Email verificata su
Citata da
Citata da
Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti, P Menna, E Salvatorelli, G Cairo, L Gianni
Pharmacological reviews 56 (2), 185-229, 2004
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancerá…
JL Zamorano, P Lancellotti, D Rodriguez Munoz, V Aboyans, ...
European heart journal 37 (36), 2768-2801, 2016
The requirement for iron (III) in the initiation of lipid peroxidation by iron (II) and hydrogen peroxide.
G Minotti, SD Aust
Journal of Biological Chemistry 262 (3), 1098-1104, 1987
Anthracycline cardiotoxicity: from bench to bedside
L Gianni, EH Herman, SE Lipshultz, G Minotti, N Sarvazyan, DB Sawyer
Journal of Clinical Oncology 26 (22), 3777-3784, 2008
In Vivo Formation of 8-Epi-Prostaglandin F Is Increased in Hypercholesterolemia
G Davi, P Alessandrini, A Mezzetti, G Minotti, T Bucciarelli, F Costantini, ...
Arteriosclerosis, thrombosis, and vascular biology 17 (11), 3230-3235, 1997
The role of iron in the initiation of lipid peroxidation
G Minotti, SD Aust
Chemistry and Physics of Lipids 44 (2-4), 191-208, 1987
An investigation into thee mechanism of citrate FE2+-dependent lipid peroxidation
G Minotti, SD Aust
Free Radical Biology and Medicine 3 (6), 379-387, 1987
Redox cycling of iron and lipid peroxidation
G Minotti, SD Aust
Lipids 27 (3), 219-226, 1992
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
J Herrmann, D Lenihan, S Armenian, A Barac, A Blaes, D Cardinale, ...
European heart journal 43 (4), 280-299, 2022
Role of iron in anthracycline cardiotoxicity: new tunes for an old song?
The FASEB Journal 13 (2), 199-212, 1999
Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidation--a potential mechanism in atherosclerosis.
A Paolicchi, G Minotti, P Tonarelli, R Tongiani, D De Cesare, A Mezzetti, ...
Journal of investigative medicine: the official publication of the Americaná…, 1999
Anthracycline cardiotoxicity
P Menna, O Gonzalez Paz, M Chello, E Covino, E Salvatorelli, G Minotti
Expert opinion on drug safety 11 (sup1), S21-S36, 2012
Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediatedá…
G Minotti, R Ronchi, E Salvatorelli, P Menna, G Cairo
Cancer research 61 (23), 8422-8428, 2001
The role of iron in oxygen radical mediated lipid peroxidation
G Minotti, SD Aust
Chemico-biological interactions 71 (1), 1-19, 1989
Doxorubicin metabolism and toxicity in human myocardium: role of cytoplasmic deglycosidation and carbonyl reduction
S Licata, A Saponiero, A Mordente, G Minotti
Chemical research in toxicology 13 (5), 414-420, 2000
The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage
G Cairo, S Recalcati, A Pietrangelo, G Minotti
Free Radical Biology and Medicine 32 (12), 1237-1243, 2002
Cardiotoxicity of antitumor drugs
P Menna, E Salvatorelli, G Minotti
Chemical research in toxicology 21 (5), 978-989, 2008
The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein‐1 in cytosolic fractions from human myocardium
G Minotti, S Recalcati, A Mordente, G Liberi, AM Calafiore, C Mancuso, ...
The FASEB journal 12 (7), 541-552, 1998
Sources and role of iron in lipid peroxidation
G Minotti
Chemical research in toxicology 6 (2), 134-146, 1993
Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms
G Minotti, S Recalcati, P Menna, E Salvatorelli, G Corna, G Cairo
Methods in enzymology 378, 340-361, 2004
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20